NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. (Q40289695)
Jump to navigation
Jump to search
scientific article published on 8 April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. |
scientific article published on 8 April 2013 |
Statements
NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128 (English)
R Nanta
D Meeker
M Rodova
P J Van Veldhuizen
S Shankar
R K Srivastava
1 reference
1 reference